Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ChemRar High Tech Center

www.chemrar.ru/eng

Latest From ChemRar High Tech Center

Russian IP Status: Adequate, But Flawed For Pharma

In recent years, Russia has adopted IP reforms that bring its patent provisions closer to international standards, but enforcement remains problematic, as are dispute proceedings, in part because there’s a lack of trained judicial experts.

BioPharmaceutical Intellectual Property

Priming Russia’s Pharma Industry For Innovation

The Russian government’s aggressive plan to modernize the country’s pharmaceutical industry is stimulating entrepreneurial activities, as well as a flurry of deal activity between local and foreign companies. Many uncertainties remain about the potential opportunities, however, as foreign companies try to sort out changing regulatory and business dynamics.

BioPharmaceutical Strategy

Deals Shaping The Medical Industry, February 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Janssen Pharma, Russia's NewVac To Develop Cancer-Treatment Drug

Janssen Pharmaceuticals and NewVac have signed an agreement to share development and marketing rights for the U.S. drug maker's quisinostat for treating solid tumors along with standard care in Eastern Europe.

BioPharmaceutical United States
See All
UsernamePublicRestriction

Register